ArticlePharmacogenomics and personalized medicine2021

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer.

Xiaoyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.